This New Device Could Change Osteoporosis Treatments!
About this video
Yurth frames osteoporosis as a major, under-addressed risk after midlife and argues for early baseline bone assessment, especially around menopause or with a family history. She criticizes bisphosphonates, arguing in her view they can raise measured density without producing resilient bone. She discusses peptide-related approaches and claims GLP-1 agonists may support bone-forming cells, then introduces a wearable vibration belt device inspired by space research. Yurth says the device delivers targeted mechanical stimulation to hip and spine, unlike whole-body vibration plates where she argues the signal dissipates, and presents it as a drug-free option she says may help stop bone loss, with less compelling evidence for regrowing bone.
Key takeaways
- Treat bone loss as a longevity priority, not just a density score
- Ask what kind of bone a treatment builds, not only whether density rises
- Consider mechanical stimulation as a drug-free adjunct Yurth discusses for hip and spine
- Get baseline bone assessment earlier when risk or family history is present
- Distinguish stopping loss from regrowing bone when judging evidence
Episode details: published May 16, 2025 · 1.7K views · 1:42 long. Summary written by Self Growth Videos from the episode itself. The longevity and peptide concepts described are Dr. Elizabeth Yurth’s, presented for education — not medical advice. Consult a qualified professional before changing your own health practices. Disclosure: Dr. Yurth is co-founder and Chief Medical Officer of the Boulder Longevity Institute, a clinic, and BLI Academy sells clinician education.
← Previous: Does Ozempic Cause Muscle Loss? · Next: Q&A Highlights - May 2025 →
All Dr. Elizabeth Yurth videos · Dr. Elizabeth Yurth profile · Boulder Longevity Institute (official site)
